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Background: Fatty acid vesicles are an important part of protocell models currently studied. As protocells can be
considered as pre-biological precursors of cells, the models try to contribute to a better understanding of the (cellular)
origin of life and emphasize on 2 major aspects: compartmentalization and replication. It has been demonstrated
that lipid-based membranes are amenable to growth and division (shell replication). Furthermore compartmentalization
creates a unique micro-environment in which biomolecules can accumulate and reactions can occur. Pioneering
research by Sugawara, Deamer, Luisi, Szostak and Rasmussen gave more insight in obtaining autocatalytic, self-
replicating vesicles capable of containing and reproducing nucleic acid sequences (core replication). Linking both core
and shell replication is a challenging feat requiring thorough understanding of membrane dynamics and (auto)catalytic
systems. A possible solution may lie in a class of compounds called nucleolipids, who combine a nucleoside, nucleotide
or nucleobase with a lipophilic moiety. Early contributions by the group of Yanagawa mentions the prebiotic
significance (as a primitive helical template) arising from the supramolecular organization of these compounds. Further
contributions, exploring the supramolecular scope regarding phospoliponucleosides (e.g. 5? -dioleylphosphatidyl
derivatives of adenosine, uridine and cytidine) can be accounted to Baglioni, Luisi and Berti. This emerging field of
amphiphiles is being investigated for surface behavior, supramolecular assembly and even drug ability.
Results: A series of α/β-hydroxy fatty acids and α-amino fatty acids, covalently bound to nucleoside-5′-monophosphates
via a hydroxyl or amino group on the fatty acid was examined for spontaneous self-assembly in spherical aggregates
and their stability towards intramolecular cleavage. Staining the resulting hydrophobic aggregates with BODIPY-dyes
followed by fluorescent microscopy gave several distinct images of vesicles varying from small, isolated spheres to
higher order aggregates and large, multimicrometer sized particles. Other observations include rod-like vesicle
precursors. NMR was used to assess the stability of a representative sample of nucleolipids. 1D 31P NMR revealed that
β-hydroxy fatty acids containing nucleotides were pH-stable while the α-analogs are acid labile. Degradation products
identified by [1H-31P] heteroTOCSY revealed that phosphoesters are cleaved between sugar and phosphate, while
phosphoramidates are also cleaved at the lipid-phosphate bond. For the latter compounds, the ratio between both
degradation pathways is influenced by the nucleobase moiety. However no oligomerization of nucleotides was
observed; nor the formation of 3′-5′-cyclic nucleotides, possible intermediates for oligonucleotide synthesis.
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Conclusions: The nucleolipids with a deoxyribose sugar moiety form small or large vesicles, rod-like structures, vesicle
aggregates or large vesicles. Some of these aggregates can be considered as intermediate forms in vesicle formation or
division. However, we could not observe nucleotide polymerization or cyclic nucleotide function of these nucleolipids,
regardless of the sugar moiety that is investigated (deoxyribose, ribose, xylose). To unravel this observation, the
chemical stability of the constructs was studied. While the nucleolipids containing β-hydroxy fatty acids are stable as
well in base as in acid circumstances, others degraded in acidic conditions. Phosphoramidate nucleolipids hydrolyzed
by P-N as well as P-O bond cleavage where the ratio between both pathways depends on the nucleobase. Diester
constructs with an α-hydroxy stearic acid degraded exclusively by hydrolysis of the 5′-O-nucleoside ester bond.
As the compounds are too stable and harsh conditions would destruct the material itself, more reactive species
such as lipid imidazolates of nucleotides need to be synthesized to further analyze the potential polymerization
process.
Keywords: Nucleolipid, Vesicles, Hydroxy fatty acids, Protocell, Chemical stability, Supramolecular assembly,
Intramolecular catalysis, Fluorescence microscopy, BODIPY, NMR stability studyBackground
Fatty acid vesicles are an important part of protocell
models currently studied [1,2]. As protocells can be
considered as pre-biological precursors of cells [3], the
models try to contribute to a better understanding of
the (cellular) origin of life and emphasize on 2 major as-
pects: compartmentalization and replication [2,4-6]. It
has been demonstrated that lipid-based membranes are
amenable to growth and division [1,7]. Small unilamellar
vesicles divide after micelle addition [8]. Autocatalytic
self-replicating micelles are formed from amphiphiles gen-
erated from the alkaline hydrolysis of ethyl caprylate (shell
replication) [4]. Furthermore compartmentalization cre-
ates a unique micro-environment in which biomolecules
can accumulate [9,10] and reactions can occur [11]. Pio-
neering research by Sugawara [12], Deamer [13], Luisi [4],
Szostak [7,14,15] and Rasmussen [16] gave more insight
in obtaining autocatalytic, self-replicating vesicles capable
of containing and reproducing nucleic acid sequences
(core replication).
Linking both core and shell replication is a challenging
feat requiring thorough understanding of membrane dy-
namics [7] and (auto)catalytic systems [4,17]. A possible
solution may lie in a class of compounds called nucleoli-
pids, who combine a nucleoside, nucleotide or nucleo-
base with a lipophilic moiety. Early contributions by the
group of Yanagawa [18] mentions the prebiotic signifi-
cance (as a primitive helical template) arising from the
supramolecular organization of these compounds. Fur-
ther contributions, exploring the supramolecular scope
regarding phospoliponucleosides (e.g. 5 ? -dioleylphospha-
tidyl derivatives of adenosine, uridine and cytidine) can
be accounted to Baglioni, Luisi and Berti. This emerging
field of amphiphiles is being investigated for surface be-
havior, supramolecular assembly and even drug ability
[19,20]. Besides improving permeability, modifying medi-
cinally active nucleosides or nucleotides with long alkylchains has proven (also by our group) to be an adequate
prodrug tactic [10,21].
Now we designed of a series of nucleolipids as possible
activated precursors for obtaining oligonucleotides. Besides
its role as supramolecular recognition element ensuring
the vicinity of the nucleophilic 2′- and 3′-hydroxyl groups
and the electrophilic (activated) phosphate, it is necessary
that the lipid part of the conjugate is also a good leaving
group. This may be achieved by intramolecular catalysis; as
we have recently demonstrated that a carboxylic acid func-
tion introduced in α-position of a phosphoramidate or
phosphodiester group may help in catalyzing the cleavage
of the phosphoramidate or phosphodiester bonds. This oc-
curs by means of a cyclic intermediate that forms under
(mild) acidic conditions (Scheme 1b). One must also con-
sider the competing acidic hydrolysis (Scheme 1a) and
cleavage of the ester bond between nucleoside and phos-
phate (not depicted). Previous results have shown that the
cleavage ratio of Nucleoside-O-P and P-X-leaving group
depends on the nature of the latter bond, the leaving group
(with or without nearby carboxyl group), nucleobase and
pH (a more detailed discussion of these factors can be
found in the work of Maiti et al [22]).
Depending on the cleaved bond, this might lead to
oligonucleotide formation due to the leaving group prop-
erties of the lipid moiety or through the formation of cyc-
lic nucleotides, (e.g. 3′-5′ cyclic GMP) which are able to
polymerize in water to give short RNA fragments [23]. As
the properties of the phospholipids with and without nu-
cleoside are different, the potential of obtaining a dynamic
system is present.
Here, we have investigated the potential of α/β-hydroxy
fatty acids and α-amino fatty acids, covalently bound to
nucleoside-5′-monophosphates via a hydroxyl or an amino
group on the fatty acid (Figure 1) to spontaneous self-
assemble in spherical aggregates. Their stability towards
intramolecular cleavage was examined and thus their
Scheme 1 Rationale behind the design of a new series of nucleolipid containing hydroxy/amino fatty acid with a free α/β carboxyl
group. Plain acid promoted nucleophilic cleavage (a) and by carboxyl group mediated, intramolecular catalyzed nucleophilic cleavage (b).
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nucleotide synthesis was assessed.Results and discussion
Chemistry
Several types of phospholipid conjugates of nucleotides
were synthesized as represented by structure A and B
(Figure 1). A stearic acid scaffold should provide an opti-
mal balance between membrane fluidity and sufficient
permeability [2]. A nucleoside moiety consists of either a
(deoxy)ribofuranose or a xylofuranose linked to thymine
or adenine; thus creating amphiphiles with large, polar
head groups.
The (?)- α-hydroxy stearic acid 3 is prepared in two
steps from stearic acid 1 by bromination [24] using Hell-
Volhard-Zelinsky condition giving compound 2 followed
by hydrolysis in 88% overall yield (Scheme 2). The (?)- β-
Hydroxy stearic acid 8 is synthesized by the procedure
described by Masamune [25,26], which involves homolo-
gation of palmitic acid 5 [27] using in situ generated
magnesium monomethylmalonate to a preformed acyl
imidazole to produce the β-keto stearic acid methyl
ester, which is reduced [28] with sodium borohydride in
ethanol providing 7. Saponification with 1 N NaOHFigure 1 General structure of nucleolipids studied in this manuscript:
and b: β-hydroxystearic acid.resulted in the formation of (?)- β-hydroxy stearic acid 8
in 77% overall yield (Scheme 3).
The benzyl esters of α-hydroxy stearate 4 was synthe-
sized [29] by heating α-hydroxystearic acid 3, with ben-
zyl bromide in presence of triethylamine, and catalytic
amount of TBAI in toluene for 12 h in a yield of 56%.
The benzyl ester of β-hydroxy stearate 9 is prepared in a
similar way.
The phosphoramidite approach is used for the synthesis
of the lipid-nucleotide conjugates. The phosphoramidites of
(?)- α- 12 and (?)- β-hydroxy benzyl stearate 13 (Scheme 4)
were prepared by reaction of 4 and 9, respectively, with the
phosphoramidite reagent 11 (Scheme 4), which was ob-
tained by reaction of bis(diisopropylamino)chlorophosphine
[30] 10 with benzyl alcohol.
The protected 2′-deoxyadenosine 14 and adenosine
16 were prepared in a similar manner as previously de-
scribed [31,32]. Likewise, protected thymidine 15 was
prepared according to a previously reported procedure
[31,32] (Scheme 5).
The 2′, 3′-O-protected xylofuranose derivative 27 with
an adenine base moiety (Scheme 6) was prepared, starting
from commercially available diacetone-D-glucose 17.
Benzoylation of 17 was carried out using sodium hy-
dride and benzyl bromide in dry dimethylformamide.a: α-hydroxystearic acid (X = O), α-aminostearic acid (X = NH)
Scheme 2 Synthesis of (?)- α hydroxy stearate. a) PBr3, Br2, 95?C, 6 h; b) 2 M NaOH, 85?C, 2 h; c) Et3N, BnBr, TBAI, toluene, reflux 12 h.
Scheme 3 Synthesis of (?)- β hydroxy stearate. a) 1,1′-carbonyldiimidazole, magnesium methylmalonate, THF, rt 24 h; b) NaBH4, EtOH,
rt,15 min; c) 1 N NaOH, 15 min rt; d) Et3N, BnBr, TBAI, toluene, reflux 12 h.
Scheme 4 Synthesis of the phosphoramidite reagents. a) BnOH, Et3N, Et2O; b) 4, dry DCM, 1H-Tetrazole at 0?C, 15 min at rt; c) 9, dry DCM,
1H-Tetrazole at 0?C, 15 min at rt.
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Scheme 5 Sugar-protected adenine and thymine nucleoside.
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followed by oxidation with sodium periodate, and boro-
hydride reduction, afforded the 1,2-acetonide 20, in 88%
yield over three steps. After benzoylation of 20 [33,34]
and treatment of 21 with Ac2O/H2SO4, a mixture of theScheme 6 Synthesis of the protected xylofuranosyl nucleoside. a) NaH
c) NaIO4, H2O rt, NaBH4, EtOH 0?C - rt 2 h; d) benzoyl chloride, pyr; e) aceti
MeOH, rt, 2d; h) dry DMF, Imidazole, TBDMSCl. 24 h, rt; i) dry DCM, DMAP,anomers of 1,2-di-O-acetyl-3-O-benzyl-5-O-benzoyl-D-
xylofuranose 22 was obtained. Condensation of 22 with
N6-benzoyladenine [35,36], provided the desired β-anomer
23 in 86% yield.
Deprotection of 23 was carried out by using saturated
methanolic ammonia to give the nucleoside 24 in 68%
yield. The selective silylation of the 5′-hydroxyl group of
compound 24 was carried out with TBDMSCl, imidazole
in dry DMF to obtain nucleoside 25. The 2′-hydroxyl
group of compound 25 was protected with a carbobenzy-
loxy group. Finally, the 5′-O-TBDMS group is removed
with 1 M TBAF in dry THF to obtain compound 27.
The synthesis of the phosphotriesters was accomplished
in a one-pot method by reacting 12 and 13 with the pro-
tected nucleosides 14, 15, 16 and 27 in the presence of
1H-tetrazole followed by oxidation with hydrogen perox-
ide at -78?C, resulting in the phosphotriesters 29, 32, 35,
38, 41, 44, 46, and 48 (Scheme 7).
Deprotection of the benzyl and the carbobenzyloxy
group of phosphotriesters 32 and 41 was performed by, DMF, BnBr, 0?C - rt 24 h; b) 1:1 methanol/1% aqueous sulfuric acid;
c acid, acetic anhydride, H2SO4; f) SnCl4, acetonitrile, rt 5 h; g) NH4OH,
CbzCl, 72 h, rt; j) HF in pyridine, pyridine, rt 4 h.
Scheme 7 Synthesis of the ribose and deoxyribose nucleolipids. a) 12,1H-tetrazole, dry DCM, rt 4 h; b) 13, 1H-tetrazole, dry DCM, rt 4 h;
c) H2O2, -78?C - rt, 30 min; d) H2, Pd/C, THF, K2CO3, H2O, rt 48 h, for 32 and 41, MeOH was used as co-solvent without adding K2CO3. 30, 36, 39
and 45 were isolated as 2 K+ salt.
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Hydrogenolysis in THF/H2O as solvent in the presence of
K2CO3, was carried out for the deprotection of the phos-
photriesters of the adenine derivatives (29, 35, 38, 44, 46,
and 48) to obtain phosphodiesters 30, 36, 39, 45, 47, 49.
α-(?)-Aminostearic acid 50 was synthesized based on
the method reported by Toth [37] and Porter [38], starting
from 1-bromohexadecane and diethylacetamido malonate.
The crude material was directly used for esterification to
obtain compound 50 (Schemes 8 and 9).
The synthetic protocol, used for the synthesis of the
phosphoramidates of dAMP 51 and dTMP 53 was based
on literature prescription [39,40] using dicyclohexylcar-
bodiimide (DCC) as coupling agent for the conjugation
of nucleotides and amino acid. The phosphoramidates
51, 53 were obtained by refluxing the nucleoside mono-
phosphates and the amino acid methyl ester in t-BuOH
and water (5:1) in the presence of DCC (dicyclohexyldi-
carbodiimide). Deprotection of methyl ester was per-
formed using 0.5 N NaOH in MeOH/H2O-5:1 at roomtemperature for 4 h result in the phosphoramidates 52
and 54.
The self-assembling properties of these nucleolipids
were analyzed by fluorescent microscopy using water
soluble, and organic soluble (chloroform) fluorescent
dyes 55 and 56 respectively (Figure 2). Synthesis of the
new, water-soluble BODIPY dye 55 was carried out by
conjugating 8-S-Methyl BODIPY [41] with taurine in
presence of sodium hydrogen carbonate in DMSO:DCM
(1:1) at room temperature. BODIPY 56 was prepared ac-
cording to the procedure previously reported by Dehaen
[42,43] at rt.
The nucleolipids, which have been analyzed, consist of
an α-hydroxy fatty acid (30, 33, 36, 47), a β-hydroxy
fatty acid (39, 42, 45, 49) or a α-amino fatty acid (52, 54).
The polar head group is a nucleoside monophosphate
(dAMP or dTMP) connected to the lipid by a phospho-
diester (30, 33, 36, 39, 42, 45, 47, 49) or by a phosphora-
midate bond (52, 54). The sugar is either a deoxyribose
(30, 33, 39, 42, 52, 54), or a ribofuranose (36, 45) or a
Scheme 8 Synthesis of xylose nucleolipids. a) 12, dry DCM,1H-tetrazole, H2O2, rt, 4 h.; b) 13, dry DCM, 1H-tetrazole, H2O2, rt, 4 h.; c) H2, Pd/C,
THF, rt, 48 h. Compounds 47 and 48 were isolated as 2Na+ salt.
Scheme 9 Synthesis of the phosphoramidate nucleolipids. a) dAMP, DCC, t-BuOH, H2O, reflux, 2 h; b) TMP, DCC, t-BuOH, H2O, reflux, 2 h;
c) 0.5 N NaOH, MeOH, rt. Compounds 52 and 54 were isolated as 2Na + salt.
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Figure 2 Structures of fluorescent dyes used for the visualization of vesicles.
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we would like to evaluate a) if the sugar moiety may influ-
ence the self-aggregation process, b) if oligomerization
may lead to DNA and/or RNA sequences, c) if it would
be possible to form 3′-O, 5′-O-cyclic phosphates in so-
lution, d) if the properties of the leaving group mayFigure 3 Representative fluorescent images of compound 30 with dy
55, 0.15 mM HCl, 7% DMSO in H2O; for 3c =1.1 mM 30, 4.4 mM 55, 0.11 mMinfluence oligomerization or cyclic phosphate formation.
For example, an α-hydroxy acid may lead to a 5-membered
intermediate and a β-hydroxy acid to a 6-membered inter-
mediate during activation of the phosphodiester bond
(Scheme 1). A phosphoramidate may be activated as leav-
ing group by acidification of the medium. A xylofuranosee 55. Final concentrations of products for 3a-b, d =1.5 mM 30, 5.7 mM
HCl, 5% DMSO in H2O. (Scale bar 10 μm).
Figure 4 Fluorescent microscopic images of the compound 33 with dye 56. Final concentrations of products for 4a-b =0.4 mM 33,
0.013 mM 56 in H2O/dioxane/THF (3: 47:50); for 4c-d =0.8 mM 33, 0.025 mM 56, 6% THF in H2O. (Scale bar 10 μm).
Figure 5 Fluorescent microscopic images of the compound 42 with dye 56. Final concentrations of products for 5a-c =0.3 mM 42,
0.009 mM 56, 5% THF in H2O. (Scale bar 10 μm).
Figure 6 Fluorescent microscopic images of the compound 52 with dye 56. Final concentrations of products for 6a-b =0.39 mM 52,
0.013 mM 56 in H2O/dioxane/THF (3: 47:50); for 6c =0.66 mM 52, 0.022 mM 56, 5% THF in H2O. (Scale bar 10 μm).
Figure 7 Fluorescent microscopic images of the compound 54 with dye 56. Final concentrations of products for 7a-c =0.3 mM 54,
0.009 mM 56, 2% THF in H2O. (Scale bar 10 μm).
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furanose. The availability of as well A as T nucleolipids
would allow us to study mixed vesicles, in which aggrega-
tion may be influenced by base pairing.
For studying the aggregation of the compounds, fol-
lowing 2′-deoxynucleolipids have been used: 30, 33, 39,
42, 52, and 54. The fluorescent Bodipy dyes (55, 56)
were used to monitor self-assembly of the nucleolipids
by visualization under fluorescent microscopy using a spin
coat method on the surface of a microscopic glass plate.
Vesicle formation of nucleolipids in water was facilitated
by adding small amounts of organic solvents to solubilize
respectively the dye (THF) or the nucleolipid (DMSO).
Soon after dissolving the nucleolipid by vortexing, a struc-
tural transition towards thermodynamically more stable
spherical structures is observed. Vesicular aggregations
are formed ranging from about a few to 10 μm (large vesi-
cles), depending on the dilution and solvent conditions.
Also irregular (small and large tubular structures) aggre-
gates are formed in some cases. A series of representative
examples (most frequently occurring aggregates) for the
phospholipids 30, 33, 42, 52, 54 are shown.Figure 8 NMR study of 30 in acid conditions (pH-5.22 in DMSO). (a) ti
NMR spectra. (b) degradation reaction of compound 30 in acidic condition
indicate cross peaks observed in the 2D spectrum depicted in C. (c) 1H-31PFigure 3 shows microphotographs of compound 30 in
H2O using dye 55 for visualization. Single vesicles are
formed (Figure 3a) as well as several vesicle aggregates in
which three (Figure 3b) or four (Figure 3c, d) water com-
partments are present. This could be intermediate stages
in vesicle association or vesicle dissociation. Some of them
(Figure 3d) are similar in morphology to the thread-like
vesicles [7], which are formed before division in daughter
vesicles. Figure 4 gives the images of compound 33 using
dye 56. Here, single, spherical vesicles are formed using
water-miscible organic solvents (Figure 4a, b), in water
vesicles tend to associate (Figure 4c, d).
Figure 5 is representative for the images observed
using compound 42 and dye 56. As well the vesicles
(5a, b, c) are observed as rod-like structures (5a, c)
which may be precursor structures for vesicle forma-
tion. Finally, the aggregates formed by the phospho-
ramidate conjugates with an adenine (52) and thymine
(54) base moiety were visualized using dye 56. The
pictures of 52 (Figure 6 in THF/dioxane) and 54
(Figure 7b, c in water) shows the start of the forma-
tion of vesicle colonies [44].me dependent degradation in acidic conditions monitored by 1D 31P
s based on characterization of hydrolysis products by NMR. Arrows
-heteroTOCSY after 1 day in acidic conditions.
Figure 9 NMR study of 52. (a) time dependent degradation in D2O. (b) HP-heteroTOCSY after 1 day in D2O. (c) HP-heteroTOCSY after 1 day
in DMSO. (d) degradation reaction of nucleolipid 52 in acidic conditions. Arrows indicate cross peaks observed in the 2D spectra depicted in
(b) and (c).
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Figure 10 Time dependent changes in 1D 31P NMR spectrum of
nucleolipid 33 in DMSO at acidic conditions. Emergence of 2
degradation products coming from phosphate (1) and Lip-OPO3 (2).
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(poly)merize and/or to form cyclic nucleotides, com-
pounds with a deoxyribose (30, 33, 39, 42, 52 and 54), a
ribose (36, 45) or a xylose (47, 49) sugar moiety were
envisaged. Both basic and acid circumstances were con-
sidered. Oligomerization could occur by an intermo-
lecular reaction in which the 2′-OH or 3′-OH group of
the sugar moiety attacks the 5′-O-phosphoester func-
tion, using the hydroxy (amino) lipid as leaving group.
The carboxylate group in the α- or β-position may
catalyze this reaction. Alternatively, a 3′-O, 5′-O-cyclic
nucleotide may be formed (by intramolecular reaction)
which could oligomerize in solution. During the synthe-
sis of the compounds, we already observed that some of
them are not stable in acidic medium. Therefore, all
compounds were treated in acid and in base medium
(pH4 and pH12) for a period of 48 h. However in none
of the cases, polymerization products were detected using
NMR spectroscopy. These negative results could be ex-
plained by the high chemical stability of the nucleolipids
(only starting material present) or by hydrolysis of the
compounds in acidic and/or basic medium. Therefore, we
have evaluated this stability for representative examples
(30, 33, 52, 54).
31P NMR was used to study the stability of the nucleo-
lipids in acidic (pH4) and in base (pH12) environment.
One-dimensional 31P spectra were used as a fast screening
experiment to monitor degradation of the conjugates.
Two-dimensional 1H-31P correlation spectra were used to
characterize the 31P containing products formed by deg-
radation of the nucleolipids. Correlations were established
using a heteroTOCSY experiment with a DIPSI spinlock
of 50 ms, allowing correlations of 31P resonances with sev-
eral 1H resonances of adjacent spin systems.
The β-hydroxystearic acid containing nucleolipids (39,
42, 45, 49) are stable in both acidic and basic conditions
with no difference in the 31P and 1H NMR signals over
time at different pH ? s. All other compounds are stable in
basic conditions (pH = 12 in D2O) while degradation oc-
curs in acidic conditions. For phosphate diesters, a gel is
formed instantly upon lowering pH in water. Although
(hydro)gelation is an interesting property and promising
application of nucleolipids, this was not further investi-
gated [45]. Due to hampered NMR measurements in
aqueous conditions, sample degradation in acid medium
was monitored in DMSO.
An example NMR study on an nucleolipid diester with
α-hydroxy stearic acid is given in Figures 8 and 9 for
compound 30. Original 31P signals appear in 1D 31P spec-
tra between 0.1 and 0.0 ppm corresponding to Cα in R
and S enantiomers in nucleolipid 30. Due to degradation
in acidic conditions, a new 31P signal rises slightly down-
field (0.4 ppm) while the original signals decrease. In a
2D-heteroTOCSY the original signals close to 0 ppmcorrelate with protons in the spin systems of the ribose
ring (5′/5″/4′) as well as the lipid (α, β, γ). The new signal
at 0.4 ppm only correlates with protons of the lipid (α, β,
γ), indicating that the covalent bond between lipid and
phosphorus still exists after degradation. In acidic medium
(pH4-5), the thymidine congener 33 is degraded in the
same way as the adenine congener 30, which shows that
the cleavage mechanism is not dependent on the nucleo-
base (Figure 10).
Decomposition of the phosphoramidate 52 was first
studied in aqueous, acidic conditions (Figure 10). We ob-
served decrease of the original 31P signal (7 ppm) in D2O
while to signals rose at 2 and 1 ppm. The latter were
assigned to dAMP and inorganic phosphate respectively
using [1H,31P]-heteroTOCSY. Since the ratio of both new
signals is constant over time, we suggest that initial cleav-
age occurs at both amide and ester bonds in the P linkage
yielding dAMP and dA respectively. While dAMP is stable
in the reaction medium, the phosphorylated lipid rapidly
undergoes hydrolysis releasing inorganic phosphate. In
DMSO, stability of the phosphorylated lipid is increased,
making it observable as an intermediate in 1D and 2D
NMR spectra (31P signal at 8.8 ppm). The H8 signals from
the nucleobases in 52, dAMP and dA are nicely resolved
and allowed to determine a ratio of 1/4 for dAMP and dA
formation:20% of adenosine monophosphate and lipid are
formed via pathway A and 80% of deoxyadenosine, inor-
ganic phosphate and lipid are formed in pathway B. The
thymine containing congener of 52 (54) also follows both
degradation pathways in acidic conditions: 53% pathway A
with formation of dTMP and lipid and 47% pathway B
with formation of thymidine, inorganic phosphate and the
lipid. Indicating that the nucleobase influences the ratio
between P-O and P-N bond cleavage.
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α-amino compounds have shown the desired, however
nucleobase dependent, bond breakage upon acidifying;
the only problem being that the nucleophile is water and
not the 2? - or 3? - hydroxyl groups. The β-hydroxystearic
acid containing nucleolipids are stable in both acidic and
basic conditions. This difference between α and β deriva-
tives is analogues to previous calculations (done on a
model in which the nucleoside had been replaced by a me-
thyl group), showing that the formation of a six-membered
intermediate by the attack of the β-carboxyl group is
higher in energy (5 kcalmol-1) than the five-membered
ring formed by an α-carboxyl group [22]. The proposed
mechanism, predicting acidic instability, in Scheme 1b is
supported by the fact that only amino derivatives cleaved
at the desired bond, due to the preferred protonation of a
phosphoramidate over a phosphodiester.
Experimental
Benzyl 2-hydroxyoctadecanoate (4)
To a solution of α-hydroxy stearic acid 3 (10 g,
33.28 mmol), triethylamine (6.73 g, 9.25 ml, 66.56 mmol),
TBAI (1.23 g, 3.33 mmol) in toluene (150 mL), benzyl
bromide (5.7 g, 5.03 mL, 33.3 mmol) is added, and held at
90?C overnight. After the completion of the reaction, the
reaction mixture is triturated with diethyl ether, the pre-
cipitate formed was washed with ether and dried to obtain
the desired compound 4 as white solid (7.25 g, 55.7%). 1H
NMR (300 MHz, CDCl3, ppm): δ 7.37 (m, 5H, Ar), 5.25
(q, 2H, CH2), 4.23 (m, 1H), 2.79 (br, 1H, -OH), 1.82-
1.73 (m, 1H), 1.69 (m, 1H), 1.25 (s, 28H, -CH2), 0.90
(t, -CH2).
13C NMR (300 MHz, CDCl3, ppm): δ 175.41(C =
O), 135.37(-C-), 128.75 (-C-Ar), 128.65 (-C-Ar), 128.44 (-C-
Ar), 70.64 (-C-H), 67.36 (Ar-CH2), 34.52 (-CH2), 32.05
(-CH2), 29.82 (-CH2), 29.79 (-CH2), 29.66 (-CH2), 29.58
(-CH2), 29.49 (-CH2), 24.78 (-CH2), 22.81(-CH2), 14.24
(-CH3). HRMS (ESI+) m/z Calculated for C25H43O3
(MH+): 391.3212 found 391.2869. C25H42O3Na (MNa+):
413.3031 found 413.2918.
Benzyl 3-hydroxy stearate (9)
To a solution of β-hydroxy stearic acid 8 (2 g, 6.65 mmol),
triethylamine (1.2 ml, 8.65 mmol), and TBAI (0.25 g,
0.66 mmol) in toluene, benzyl bromide (1.14 g, 0.8 mL,
6.65 mmol) was added, and stirred at 90?C overnight.
After the completion of the reaction, the reaction mixture
is triturated with diethyl ether, and the precipitate formed
was washed with diethyl ether (2 ? 50 mL). The residue
obtained was purified on silica gel column chromatog-
raphy using dichloromethane to obtain the desired com-
pound 9 [46] as white solid (1.47 g, 56%). 1H NMR
(300 MHz, CDCl3): 7.34(m, 5H-Ph), 5.14 (s, 2H, CH2-
Ph), 4.01 (m, 1H), 2.9 (br s, 1H, OH), 2.58-2.41 (m, 2H,
CH2), 1.43(m, 2H, CH2), 1.41(m, 2H, CH2), 1.25 (s, 24H,CH2), 0.9 (t, 3H, CH3).
13C (300 MHz, CDCl3):172.50 (C =
O), 135.32(C-Ph), 128.28(C-Ph), 128.02(C-Ph),127.92
(C-Ph), 67.73(C, C-OH), 66.12(C, CH2-Ph), 41.08 (C,
CH2),36.24 (C, CH2), 31.60 (C, CH2), 29.37 (C, CH2),
29.34 (C, CH2), 29.26 (C, CH2), 29.24 (C, CH2), 29.20
(C, CH2), 29.03 (C, CH2), 25.14 (C, CH2), 22.36 (C,
CH2), 13.78 (C, CH3). HRMS(ES+) m/z Calculated for
C25H42O3 (MH+): 391.3206, found 391.3199.
Benzyl, (benzyl stearate)-2-yl, N, N-diisopropyl
phosphoramidite [(?)-12]
To a stirring mixture of benzyloxy bis(N, N ? -diisopropy-
lamino)phosphine (10 g, 29.55 mmol) and alpha-hydroxy
benzyl stearate (5.77 g, 14.77 mmol) in dry DCM (100 mL),
was added 0.5 M solution of 1H-Tetrazole (29.6 mL,
14.77 mmol) in ACN dropwise at 0?C. After the addition,
cooling bath was removed and the reaction mixture was
allowed to stir at rt for 15 min. The reaction mixture
was diluted with DCM (200 mL), and the organic layer
was washed with 1 M TEAB solution. The extracts were
dried over Na2SO4 and concentrated in vacuum and
purified by flash column chromatography using eluent
400:50:10-Hexane:EtOAc:TEA (Rf = 0.5) to obtain the
phosphoramidite 12 (7.10 g, 71%). P31 NMR (CDCl3): δ
149.10, 148.69.
Benzyl, (benzyl stearate)-3-yl, N, N-diisopropyl
phosphoramidite [(?)-13]
To a stirring mixture of benzyloxy Bis(N, N? -diisopropyla-
mino) phosphine (11, 1.74 g, 5.12 mmol) and β-hydroxy
stearic benzyl ester (9, 1 g, 2.56 mmol) in dry DCM
(10 mL) was added 0.5 M solution of 1H-tetrazole
(5.12 mL, 2.56 mmol) in ACN dropwise at 0?C. After the
addition, cooling bath was removed and the reaction mix-
ture was allowed to stir at room temperature for 15 min.
The reaction mixture was diluted with DCM (150 mL),
and was washed with 1 M TEAB (100 mL) solution.
Dichloromethane layer was dried over Na2SO4 and con-
centrated in vacuo, and the obtained oil was purified by
silica gel flash column chromatography using the eluent
400:50:10-Hexane:EtOAc:TEA (Rf = 0.5) to get 13 as an
pale yellow oil (0.985 g, 61%). 31P NMR (300 MHz,
CDCl3, ppm): δ 147.63, 147.07.
3-O-benzyl-1,2:5,6-Di-O-isopropylidene-α-D-glucofuranose
(17)
To a stirring solution of diacetone glucose (10 g,
38.42 mmol) in anhydrous DMF at 0?C, was added
sodium hydride (60% in mineral oil (w/w), total 2.3 g,
57.63 mmol) portion wise. Stirring was continued for
1 h at 0?C, and then benzyl bromide (5.51 g, 46.10 mmol)
was added drop wise. After addition, ice bath was removed,
and stirring continued overnight at room temperature.
After completion of the reaction, excess of sodium hydride
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ice cold water (25 mL). The reaction mixture was ex-
tracted with EtOAc (4 ? 150 mL) and the combined
organic phase was dried (Na2SO4) and concentrated
under vacuum, and the residue was purified by silica gel
column chromatography using eluents hexane:ethylace-
tate-8:2 to give the title compound 17 (13 g, 96%) as oil.
1H NMR (300 MHz, CDCl3, ppm): 7.33-7.28 (m, 5H,
Ar), 5.88 (d, 1H, 1′-H), 4.68-4.62 (m, 2H, CH2-Ar), 4.56
(d, 1H, 2′-H), 4.37-4.33 (m, 1H, 5′-H), 4.16-4.06 (m,
2H, 6′-H, 6″-H), 4.01-3.96 (m, 2H, 3′-H, 4′-H), 1.47
(s, 3H, CH3), 1.41(s, 3H, CH3), 1.35(s, 3H, CH3), 1.28
(s, 3H, CH3).
13C NMR (300 MHz, CDCl3, ppm): δ
137.66, 128.33, 127.76, 127.58, 111.65, 108.86, 108.86,
105.27, 82.64, 81.68, 81.31, 72.50, 72.29, 67.35, 26.81,
26.75, 26.20, 25.40.
3-O-benzyl-1,2-O-isopropylidene-α-D-glucofuranose (18)
In a 250 mL round bottom flask 3-O-benzyl-1,2:5,6-di-O-
isopropylidene-α-D-glucofuranose (7.00 g, 19.97 mmol)
was dissolved in 1:1 methanol/1% aqueous sulfuric acid
(110 mL), and the resulting solution stirred at rt. After
completion of the reaction (approximately 5 h, monitored
by TLC), the reaction mixture was quenched with
triethylamine (pH7). The residue was concentrated in
vacuo to afford the crude residue as syrup, which was
purified by silica gel flash column chromatography
using 5% MeOH in dichloromethane, affording the title
compound 18 [33] (5.05 g, 81%) as a colorless solid. 1H
NMR (300 MHz, CDCl3, ppm): 7.31-7.28 (m, 5H, Ar),
5.91 (m, 1H, 1′-H), 4.71 (dd, 2H, CH2-Ar), 4.51 (s, 1H),
4.13 (m, 2H), 4.09 (m, 1H), 3.81 (dd, 2H), 3.03 (br, 1H),
2.02, (s, 1H), 1.47 (s, 3H), 1.29 (s, 3H). 13C NMR
(300 MHz, CDCl3, ppm): δ171.29, 137.41, 128.70, 128.64,
128.11, 127.81, 111.80, 105.16, 82.21, 81.97, 80.01, 69.11,
64.33, 60.45, 26.73, 26.22, 21.03, 14.19. HRMS (ESI+)
m/z Calculated for C16H22O6 (MH+): 311.1489, found
311.1486.
3-O-benzyl-1,2-O-isopropylidene-β-D-xylofuranose (20)
To a stirring solution of 3-O-benzyl-1,2- isopropylidene-
α-D-glucofuranose (5 g, 16.11 mmol) in water (50 mL)
was added sodium meta-periodate (4.13 g, 19.33) at room
temperature. Stirring continued until consumption of start-
ing material. The reaction mixture was diluted with etha-
nol (80 mL) and stirring continued for another 30 min.
The reaction mixture is filtered on celite and the celite pad
washed with ethanol. The filtrate was transferred to a
500 mL round bottom flask, and cooled to 0?C. Sodium
borohydride (0.67 g, 17.72 mmol) was added in small por-
tions to the filtrate. After completion of the addition, ice
bath was removed and stirring continued for 2 h at room
temperature. The reaction mixture was neutralized by drop
wise addition of acetic acid, concentrated in vacuo and theresidue is purified by silica gel column chromatography to
get the title compound 20 [33,47] (4 g, 88.5%). 1H NMR
(300 MHz, CDCl3, ppm): δ 7.37-7.28 (m, 5H, Ar-H), 5.99
(d, 1H, 1′-H), 4.73 (dd, CH2-Ar), 4.64 (s, 1H, 4-′H), 4.30
(dd, 1H, 2′-H), 3.92 (d, 1H, 3′-H), 3.91-3.1 (m, 2H, 5′-H,
5″-H), 2.24 (dd, 1H), 1.48 (s, 3H, CH3), 1.33 (s, 3H, CH3).
13C NMR (300 MHz, CDCl3, ppm): δ 137.19 (-C-, Ar),
128.78(CH, Ar), 128.31 (CH, Ar), 127.85 (CH, Ar), 111.90
(C), 105.20(C-1′), 82.87 (C-4′), 82.60 (C-2′), 80.22 (C-3′),
72.04 (CH2-Ar), 61.09 (C-5′), 26.93 (CH3), 26.43(CH3).
HRMS (ESI+) m/z Calculated for C15H20O5 [M + Na]+ :
303.1203, found 303.1207.
3-O-benzyl-1,2-O-isopropylidene-β-D-xylofuranose (21)
To a suspension of 3-O-Benzyl-1,2-O-isopropylidene-β-
D-xylofuranose (4 g, 14.26 mmol) in benzoyl chloride
(1.64 g, 2 mL,17.12 mmol), was added sulfamic acid
(0.55 g, 5.70 mmol). The reaction mixture was stirred at
60?C for 3 h, allowed to come to room temperature and
the reaction mixture was poured into ice cold saturated
NaHCO3 solution, and extracted with minimum amount
of diethyl ether. The organic solvents were dried on
Na2SO4 and concentrated under reduced pressure. The
residue was purified by silica gel column chromatography
using eluents hexane:ethyl acetate (8:2) to obtain the com-
pound 21 [36] (4.8 g, 91%). 1H NMR (300 MHz, CDCl3,
ppm): δ 8.01 (d, 2H), 7.54-7.51 (m, 1H), 7.40-7.37 (m, 2H),
7.30-7.26 (m, 4H), 7.24 (d, 1H), 5.99 (d, 1H), 4.70-4.60 (m,
3H), 4.57-4.48 (m, 3H), 4.04 (br s, 1H), 1.49 (s, 3H, CH3),
1.32 (s, 3H, CH3).
13C NMR (300 MHz, CDCl3, ppm):
δ166.21, 137.16, 133.03, 129.88, 129.75, 128.53, 128.31,




To a cooled solution of 5-O-benzoyl-3-O-benzyl-1,2-O-iso-
propylidene β-D-xylofuranose (4 g, 10.40 mmol) in AcOH
(40 mL) and Ac2O (15 mL) was added drop wise sulfuric
acid (1.5 mL). Stirring was continued at room temperature
until TLC analysis shows disappearance of the starting
material, the mixture was poured into ice-water, extracted
with CHCl3 (3 ? 100mL), washed with saturated NaHCO 3
(200 mL) and dried over Na2SO4. The solvent was removed
under reduced pressure and the residue is used directly in
the next step. TLC-(7:3 hexanes? EtOAc-Rf = 0.4).
To a suspension of 22 (5 g, 11.67 mmol) and N6-ben-
zoyladenine (4.2 g, 17.50 mmol) in anhydrous acetonitrile
(60 mL) was added drop wise 1 M SnCl4 in dichlorometh-
ane (23.5 mL, 23.34 mmol) under argon. The resulting
mixture was allowed to stir for 4 h at room temperature.
After completion of the reaction, saturated aq NaHCO3
was added slowly until the evolution of carbon dioxide
ceased. Then the mixture was filtered through a pad of
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(3x100 mL). The combined filtrate was washed succes-
sively with saturated aq NaHCO3 (3 ? 100 mL) and brine
(2x100 mL), dried (Na2SO4). The filtrates were concen-
trated under reduced pressure. The residue obtained was
purified by silica gel column chromatography using 3%
MeOH in CHCl3 as eluent (Rf-0.5), affording nucleoside
23 [36] (6.12 g, 86%) as a colorless solid. 1H NMR
(500 MHz, DMSO- DMSO-d6, ppm): δ 9.36 (br s, 1H,
-NH), 8.77 (s, 1H, H-2), 8.42 (s, 1H, H-8), 8.03 (dd, 5H,
Ar), 7.59 (q, 2H, Ar), 7.50 (t, 2H, Ar), 7.43 (t, 2H, Ar),
7.27 (m, 5H, Ar), 6.44 (s, 1H, H-1′), 5.54 (s, 1H, H-2′),
4.76 (dd, 2H), 4.74 (dd, 1H), 4.65 (m, 1H), 4.16 (d, 1H),2.18
(s, 3H, CH3).
13C NMR (500 MHz, DMSO- d6, ppm): δ
169.69 (C = O, CH3), 166.38 (C = O, Ar), 164.63 (C =O,
Ar-NH), 153.03 (C-2), 151.57 (C-6), 149.58 (C-4), 141.81
(C-8), 136.24 (CH-Ar), 133.84 (CH-Ar), 133.45 (CH-Ar),
132.92 (CH-Ar), 129.88 (CH-Ar), 129.68 (CH-Ar), 129.02
(CH-Ar), 128.84 (CH-Ar), 128.59 (CH-Ar), 128.39 (CH-
Ar), 127.99 (CH-Ar), 122.92 (CH-Ar), 87.82(1′-C), 81.18
(4′-C), 79.98 (3′-C), 79.75 (C-2′), 72.36 (CH2-Ar), 62.43
(C-5′), 20.99 (CH3). HRMS (ESI+) m/z Calculated for
C33H29N5O7 (MH+): 608.2139, found 608.2135.9-(3′-O-benzyl) β-D-xylofuranosyl)-adenine (24)
To a solution of nucleoside 23 (2 g, 3.29 mmol) in
MeOH (20 mL) was added saturated methanolic ammo-
nia (100 mL) in a sealed tube and the mixture was
stirred at 85?C for 3 h. After completion of the reaction,
the reaction mixture was concentrated to dryness under
reduced pressure and the residue was coevaporated with
toluene (5x10 mL). The residue obtained was purified by
column chromatography using 5% MeOH in CHCl3 to
afford nucleoside 24 (0.8 g, 68%). 1H NMR (500 MHz,
DMSO-d6, ppm): δ 8.17 (s, 1H, H-2), 8.14 (s, 1H, H-8),
7.35-7.27 (m, 7H, Ar, -NH2), 6.04 (d, 1H, 2′-OH), 5.95
(s, 1H, 1′-H), 4.94 (br, 2H, 5′-OH), 4.68 (s, 1H, 2′-H), 4.67
(dd, 2H, CH2), 4.34 (m, 1H, 4′-H), 4.05 (br s, 1H, 3′-H),
3.81-3.73 (m, 5′-H, 5″-H). 13C NMR (500 MHz, DMSO-
DMSO-d6, ppm): δ 156.04 (C-6), 152.67(C-2), 149.21 (C-
4), 139.01 (C-8), 138.04(-C-, Ar), 128.29(-CH, Ar), 127.56
(-CH, Ar), 127.40 (-CH, Ar), 118.67(C-5), 88.74 (1′-C),
82.68 (3′-C), 77.26 (2′-C), 71.29 (CH2-Ar), 59.44 (5′-C).
HRMS (ESI+) m/z Calculated for C17H19N5O4 (MH+):
358.1509, found 358.1510.9-(5′-O-tert-butyldimethylsilyl-3′-O-benzyl)
β-D-xylofuranosyl) adenine (25)
To a cooled suspension of 9-(5′-O-tert-butyldimethylsilyl-
3-O-Benzyl-β-D-xylofuranosyl)-adenine (6 g, 16.78 mmol)
and imidazole (2.85 g, 41.97 mmol) in anhydrous N, N-
dimethylformamide was added tert-butyldimethylchloro
silane (3.03 g, 16.78 mmol) in anhydrous DMF underargon. The reaction mixture was allowed to stir for 20 h at
room temperature. After completion of the reaction, the
organic solvent was removed under high vacuum. The
residue was dissolved in 150 mL of ethyl acetate, the solu-
tion was washed with two times 80 mL of water, and one
time with 30 mL of brine and the extract was dried on
Na2SO4 and the organic solvent was concentrated under
reduced pressure. The residue obtained was purified on
silica gel column chromatography using 2% MeOH in
DCM to obtain the compound 25 as colorless solid
(7.56 g, 95%). 1H NMR (500 MHz, CDCl3, ppm): δ 8.16 (s,
1H, H-2), 8.11 (s, 1H, H-8), 7.33 (m, 7H, Ar, -NH2), 6.05
(d, 1H, 2′-OH), 5.96 (d, 1H, 1′-H), 4.69 (s, 2H, 2′-H),
4.66-4.53 (m, Ar-CH2), 4.32 (m, 1H, 4′-H), 4.06 (m, 1H,
3′-H), 4.00-3.86 (m, 2H, 5′-H, 5″-H), 0.85 (s, 9H,
-(CH3)3), 0.02 (s, 6H, -(CH3)2).
13C NMR (500 MHz,
DMSO-d6, ppm): δ 155.85(C-6), 153.79 (-C = O, Cbz)
153.16(C-2), 149.52 (C-4), 139.04(C-8), 136.70 (-C-),
134.41 (-C-), 128.83 (-CH-, Ar), 128.68 (-CH-, Ar), 128.53
(-CH-, Ar), 128.50, (-CH-, Ar) 128.17 (-CH-, Ar), 127.91
(-CH-, Ar), 119.30 (C-5), 86.89 (C-1′), 83.31 (C-4′), 82.91
(C-3′), 79.92 (C-2′), 72.45 (-CH2, Bn), 70.57 (-CH2, Cbz),
60.37 (C-5′), 25.88 (-(CH3)3), 18.29 (-C-), -5.31 (CH3), -5.42
(CH3). HRMS (ESI+) m/z Calculated for C23H33N5O4Si1
(MH+): 472.2374, found: 472.2379.(9-(5′-O-tert-butyldimethylsilyl-3′-O-benzyl-2′-O-
benzyloxycarbonyl) β-D-xylofuranosyl) adenine (26)
To a solution of 9-(5′-O-tert-butyldimethylsilyl-3′-O-
Benzyl-2′-O-benzyloxycarbonyl-β-D-xylofuranosyl)-aden-
ine (2.5 g, 53 mmol) and DMAP (1.3 g, 10.60 mmol) in
50 mL of anhydrous dichloromethane was added benzyl
chloroformate (CbzCl, 1.8 g, 1.78 mL, 10.60 mmol) at 0?C
under argon atmosphere. After stirring for 72 hours at
room temperature, the reaction mixture was diluted with
DCM (200 mL) and washed with cold 1.0 M HCl aqueous
solution (50 mL) and then with water (100 mL). The or-
ganic layer was dried over anhydrous NaSO4, filtered, and
concentrated under reduced pressure. The residue ob-
tained, was purified by silica gel column chromatography
(hexane/EtOAc-10:1 to 1:1 v/v) to obtain 26 (2.85 g, 89%).
1H NMR (500 MHz, CDCl3, ppm): δ 8.25 (s, 1H, H-2),
8.05 (s, 1H, H-8), 7.28-7.17 (m, 10H, Ar), 6.38 (br, m,
2H, -NH2), 6.29 (s, 1H, 1′-H), 5.11 (s, 2H, CH2-Cbz)
4.64 (s, 2H, 2′-H), 4.61-4.52 (m, Ar-CH2), 4.27 (m, 1H,
4′-H), 4.10 (d, 1H, 3′-H), 3.97-3.87 (m, 2H, 5′-H, 5″-H),
0.82 (s, 9H, -(CH3)3), 0.01 (s, 6H, -(CH3)2).
13C NMR
(500 MHz, CDCl3, ppm): 155.85, 153.79, 153.16, 149.52,
139.04, 136.70, 134.41, 128.83, 128.68, 128.53, 128.50,
128.17, 127.91, 119.30, 86.89, 83.31, 82.91, 79.92, 72.45,
70.57, 60.37, 25.88, 18.29, -5.31, -5.42. HRMS (ESI+) m/z
Calculated for C31H39N5O6Si1 (MH+): 606.2742, found:
606.2729.
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adenine (27)
To a solution of 26 (2 g, 33 mmol) in 30 mL of anhydrous
THF was added 1 M TBAF in THF (8.63 g, 330 mmol) at
0?C under N 2 atmosphere. The solution was stirred for
12 h at room temperature, and all volatiles were removed
using a rotary evaporator. The residue was dissolved in
EtOAc (100 mL) and washed with cold saturated NaHCO3
solution (30 mLx2), and brine (30 mL). The organic solvent
was dried over Na2SO4 and filtered. The filtrate was
concentrated and the obtained residue was purified by silica
gel column chromatography (CH2Cl2/MeOH-9:1) to give
27 (1.41 g) as white solid in 86% yield. 1H NMR (500 MHz,
CDCl3, ppm): δ 8.15 (s, 1H, H-2), 8.14 (s, 1H, H-8), 7.37-
7.28 (m, 10H, 2xAr), 6.20 (s, 1H, 1′-H), 5.71 (t, 1H, 2′-H),
5.17 (s, 2H, -NH2), 5.03 (t, 1H, 5′-OH), 4.75 (dd, 2H, CH2-
Ar), 4.38 (m, 1H, 4′-H), 4.30 (m, 1H, 3′-H), 3.78 (m, 2H,
5′-H, 5″-H). 13C NMR (500 MHz, CDCl3, ppm): 156.05,
153.24, 152.81, 149.14, 138.68, 137.57, 134.96, 128.53,
128.51, 128.32, 128.31, 127.70, 127.53, 118.52, 85.67,
82.58, 81.98, 79.90, 71.46, 69.75, 59.07. HRMS (ESI+)
m/z Calculated for C25H25N5O6 (MH+):492.1877, found:
492.1881.3′-O-benzyloxycarbonyl-2′-deoxyadenosine-5′-(O-(benzyl
stearate)-2-yl, O-benzyl) phosphate (29)
To a stirred solution of 14 (1 g, 25.94 mmol) and 12
(2.45 g, 38.92 mmol) in 5 mL dry DCM was added
0.5 M solution of 1H-Tetrazole (25.94 mL, 129.74 mmol)
drop wise at 0?C. The reaction mixture was allowed to
stir at room temperature for 4 h. Then the reaction
mixture was cooled down to -78?C and hydrogen perox-
ide 35% (W/V, 10 mL) was added. After stirring for
5 min at -78?C, cooling bath was removed and the reac-
tion mixture was allowed to stir at room temperature
for further 30 min. The reaction mixture is diluted with
DCM (150 mL) and washed with 1 M phosphoric acid
(70 mL), 5% aq. sodium bicarbonate (70 mL) and with
brine (60 mL), dried over sodium sulfate, filtered and
concentrated in vacuo. The obtained residue was puri-
fied by column chromatography using EtOAc to obtain
the title compound 29 as oil. 1H NMR (300 MHz,
DMSO-d6, ppm): δ 8.33 (m, 1H, H-2), 8.18 (m, 1H, H-
8), 7.38 -7.26 (m, 15H, Ar-H), 5.64 (br s, 1H), 5.34-5.04
(m, 6H, 3xCH2), 4.90-4.82 (m, 1H), 4.32 (m, 2H), 2.17
(s, 1H), 1.78 (m, 2H), 1.25 (m, 28H, CH2), 0.89 (t, 3H,
CH3).
13C NMR (500 MHz, DMSO-d6, ppm): δ 170.16,
155.59, 154.37, 153.28, 139.08, 138.93, 134.83, 128.85,
128.72, 128.55, 128.18, 128.13, 128.01, 127.97, 120.04,
84.20, 83.03, 82.92, 70.31, 67.40, 37.55, 33.09, 32.06,
29.84, 29.79, 29.65, 29.49, 19.16, 24.66, 22.82, 14.24.
HRMS (ESI+) m/z Calculated for C50H67N5O10P1 (MH+):
928.4619, found 928.4582.2′-deoxyadenosine-5′-(O-stearic acid-3-yl) phosphate (30)
To the solution of 29 (0.2 g, 0.21 mmol) in THF, K2CO3
(60 mg, 4.31 mmol) and water (2 mL) is added, followed
by Palladium (10%) on charcoal, and stirring continued
at room temperature under Hydrogen for 72 h. After
completion of the reaction, the mixture is filtered on
celite 545, and the celite pad was washed with THF:
Water-1:1, and the filtrate was evaporated and purified
by column chromatography using eluent DCM:MeOH:
H2O-17:7:1 to obtain the potassium salt of 30 as white
solid. 1H NMR (500 MHz, DMSO-d6, ppm): δ 8.37 (d,
1H, H-2), 8.12 (d, 1H, H-8), 7.25 (t, 2H), 6.37 (m, 1H),
5.43 (br s, 1H), 4.44 (br, 1H) 4.29 (m, 1H), 3.96 (t, 1H),
3.90-3.85 (m, 1H), 3.78 (m, 1H), 2.74 (m, 1H), 2.28 (m,
1H), 1.66 (m, 1H), 1.511 (m, 1H), 1.23 (m, 28H), 0.86 (t,
3H). 13C NMR (500 MHz, DMSO-d6, ppm): 172.98,
172.89, 156.12, 152.02, 152.53, 152.39, 149.22, 149.17,
148.91, 139.57, 139.24, 139.11, 119.28, 119.00, 118.94,
88.02, 85.97, 83.96, 83.17, 73.49, 71.17, 71.14, 71.00,
65.44, 65.18, 61.92, 50.01, 31.31, 29.06, 28.91, 28.85,
28.83, 28.72, 24.65, 22.12, 13.99. 31P NMR (500 MHz,
DMSO-d6, ppm): 1.31, 1.21. HRMS (ESI-) m/z Calculated
for C28H47N5O8P1 (MH-): 612.3167, found 612.3171.3′-O-benzyloxycarbonyl-thymidine-5′-(O-(benzyl stearate)-
2-yl, O-benzyl) phosphate (32)
To the stirring solution of 15 (2 g, 5.31 mmol) and 12
(5 g, 8 mmol) in dry DCM (5 mL), was added 0.5 M so-
lution of 1H-Tetrazole (53 mL, 26.57 mmol) drop wise
at 0?C and the reaction mixture was stirred at rt for 4 h.
Then the reaction mixture was cooled down to -78?C
and hydrogen peroxide 35% (W/V, 15 mL) was added.
After stirring for 5 min at -78?C, cooling bath was re-
moved and the reaction mixture was allowed to stir at rt
for 30 min. The reaction mixture is diluted with DCM
(200 mL) and washed with 1 M phosphoric acid (100 mL),
dilute sodium bicarbonate (100 mL) and with brine
(100 mL), dried over sodium sulfate, filtered, concentrated
in vacuo. The obtained pale yellow oil was purified by col-
umn chromatography using EtOAc as eluent to give the
desired compound 32 as oil (4.35 g, 89%). H1 NMR
(CDCl3, 300 MHz, ppm): δ 8.85 (br s, 1H, -NH), 7.38 (m,
15H, 3xAr), 6.38 (m, 1H), 5.20 (m, 7H), 4.89 (m, 1H), 4.30
(m, 3H), 1.87 (m, 5H), 1.25 (m, 29H), 0.89 (t, 3H). 13C
NMR (CDCl3, 300 MHz, ppm): δ 171.15, 169.83, 169.73,
163.87, 163.78, 154.36, 154.33, 150.55, 150.51, 150.49,
150.47, 135.40, 135.36, 135.14, 135.08, 135.01, 134.93,
134.79, 134.72, 128.97, 128.93, 128.85, 128.76, 128.68,
128.51, 128.45, 128.14, 128.11, 127.99, 127.95, 111.86,
111.84, 111.63, 84.44, 82.60, 70.22, 70.17, 69.83, 67.41,
60.42, 37.26, 31.97, 29.75, 29.71, 29.67, 29.56, 29.40, 29.09,
24.67, 24.58, 22.74, 21.07, 21.05, 19.12, 14.24, 14.16, 12.40.
31P NMR (500 MHz, CDCl3, ppm): δ -1.00, -1.24, -1.80,
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(MH+): 919.4504, found 919.4512.
Thymidine-5′-(O-stearic acid-2-yl) phosphate (33)
To a stirring solutions of 32 (2 g, 2.17 mmol) in THF:
MeOH-1:1 (30 mL) was added Palladium on Charcoal
(10%), and kept for stirring under hydrogen for 6 h at
room temperature. After completion of the reaction, the
reaction mixture is passed through celite pad and the
celite pad is washed with THF-MeOH mixture (200 mL).
The organic solvents were removed under vacuum, and
the obtained white residue was purified by silica gel chro-
matography using DCM:MeOH:H2O-17:7:1. The organic
solvents were removed with a rotavapor and the aqueous
solvent was removed with a lyophilizer to get the desired
product 33 as white solid (0.81 g, 61%). 1H NMR
(300 MHz, D2O, ppm): δ 7.82 (d, 1H, NH), 6.28 (d, 1H,
H-5), 4.55 (br m, 2H), 4.14 (br m, 3H), 2.37 (m, 2H, 5′-H),
1.94 (m, 3H, CH3), 1.77 (br s, 2H, CH2), 1.42 (br, 2H), 1.18
(m, 26H, 13xCH2), 0.81 (t, 3H, CH3).
13C NMR
(300 MHz, D2O, ppm): δ 173.02, 165.43, 150.90, 136.63,
110.88, 110.77, 85.53, 84.89, 74.38, 70.84, 70.60, 64.69,
39.23, 38.98, 33.09, 31.58, 29.53, 29.40, 29.27, 29.09, 24.74,
22.27, 13.53, 11.69, 11.61. 31P NMR (300 MHz, D2O,
ppm): δ -0.80, -0.95. HRMS (ESI+) m/z Calculated for
C28H49N2O10P1 (MH-): 603.3051, found 603.3054.
2′,3′-O-bisbenzyloxycarbonyl, adenosine-5′-((O-benzyl
stearate)-2-yl, O-benzyl) phosphate (35)
To the stirring solution of 16 (2.5 g, 4.668 mmol) and
0.5 M solution of 1H-Tetrazole (46.7 mL, 23.34 mmol)
in anhydrous dichloromethane, was added 12 (0.88 g,
7 mmol) in dry dichloromethane, drop wise at 0?C and
the reaction mixture was stirred at rt for 4 h. Then the
reaction mixture was cooled down to -78?C and hydrogen
peroxide 35% (W/V) (15 mL) was added. After stirring for
5 min at -78?C, cooling bath was removed and the reac-
tion mixture was allowed to stir at room temperature for
30 min. The reaction mixture is diluted with DCM
(200 mL) and washed with 1 M phosphoric acid (100 mL),
5% aqueous sodium bicarbonate (100 mL) and with brine
(100 mL). Organic layer was separated and dried over so-
dium sulfate, filtered and concentrated in vacuo. The ob-
tained pale yellow oil was purified by silica gel column
chromatography with eluent EtOAc to give 35 (4.55 g,
90%) as oil. 1H NMR (500 MHz, CDCl3, ppm): δ 8.28 (d,
1H, H-2), 8.07 (d, 1H, H-8), 7.34-7.29 (m, 20H, Ar), 6.21
(dd, 1H), 5.92 (m, 1H), 5.85 (br s, 2H), 5.65 (m, 1H), 5.18
(m, 1H), 5.12 (m, 6H), 5.87(m, 1H), 4.38 (m, 2H), 1.78 (m,
2H), 1.25 (m, 28H), 0.89 (t, 3H, CH3).
13C NMR
(500 MHz, CDCl3, ppm): δ 170.13, 155.65, 154.09,
153.73, 153.47, 150.02, 139.38, 139.28, 135.27, 134.75,
134.59, 128.88, 128.85, 128.77, 128.71, 128.67, 128.600,
128.52, 128.11, 127.98, 127.92, 120.13, 85.63, 80.64,76.17, 76.06, 73.98, 73.79, 70.63, 70.57, 69.83, 67.43,
66.2633.02, 32.97, 32.05, 29.83, 29.79, 29.66, 29.48,
29.45, 29.15, 24.64, 24.59, 22.81, 14.24. 31P NMR
(500 MHz, CDCl3):-1.57,-1.61, -2.09. HRMS (ESI+) m/z
Calculated for C58H72N5O13P1 (MH+): 1078.4936, found
1078.4946.Adenosine-5′-(O-stearic acid-2-yl) phosphate (36)
To a solution of 35 (2 g, 1.85 mmol) in THF, K2CO3
(0.52 g, 37 mmol) and water (2 mL) was added. To this,
Pd (10%) on Charcoal is added and kept for stirring at
room temperature under hydrogen for 72 h. After the
completion of the reaction, the mixture is filtered on
celite 545, filtrate was washed with THF:Water-1:1. The
filtrate was concentrated in vacuo and purified by silica
gel column chromatography (DCM:MeOH:H2O-17:7:1)
to obtain the potassium salt of 33 as white solid (0.62 g,
53%). 1H NMR (500 MHz, CDCl3, ppm): δ 8.4 (br s, 1H,
H-2), 8.13 (s, 1H, H-8), 7.21 (br s, 2H, -NH2), 5.92 (d,
1H, H-1′), 5.32 (m, 1H), 4.61 (br, 1H), 4.21 (br s, 1H),
4.04 (s, 1H), 3.90 (br s, 1H), 2.08 (s, 1H), 1.68 (br, 1H),
1.52 (br, 1H), 1.22 (m, 28H), 0.86 (t, 3H, CH3).3′-O-benzyloxycarbonyl, deoxyadenosine-5′-(O-benzyl,
O-(benzyl stearate)-2-yl) phosphate (38)
To the stirring solution of 14 (0.3 g, 0.77 mmol) and 13
(0.734 g, 1.16 mmol) in 5 mL dry DCM was added
0.5 M solution of 1H-tetrazole (12.5 mL, 6.22 mmol)
drop wise at 0?C, and the reaction mixture was stirred at
room temperature for 12 h. Then the reaction mixture
was cooled down to -78?C and hydrogen peroxide 35%
(W/V) was added. After stirring for 5 min at -78?C, cool-
ing bath was removed and the reaction mixture was
allowed to stir at rt for 30 min. The reaction mixture is di-
luted with DCM and washed with 1 M phosphoric acid,
5% aq. sodium bicarbonate and with brine, dried over so-
dium sulfate, filtered and concentrated on vacuo, and
purified by column chromatography (EtOAc) which gives
38 as an oil. 1H NMR (300 MHz, CDCl3, ppm): δ7.37-
7.28 (m, 15H), 6.45 (m, 2H), 5.31 (d, 1H), 5.13-4.98 (m,
6H, 3 ? CH 2), 4.29-4.20 (m, 1H), 2.78-2.69 (m, 1H), 2.68-
2.54 (m, 1H), 1.65 (m, 2H, CH2), 1.25 (m, 26H, 13xCH2),
0.89 (t, 3H, CH3).
13C NMR (300 MHz, CDCl3, ppm): δ
169.89, 155.84, 154.25, 153.16, 149.69, 138.63, 135.73,
134.76, 128.77, 128.69, 128.57, 128.52, 128.40, 128.35,
128.26, 128.24, 128.13, 127.99, 127.96, 127.88, 127.81,
119.89, 84.08, 83.97, 82.93, 82.82, 78.32, 78.25, 76.52,
76.45, 76.38, 70.12, 69.62, 69.54, 69.46, 66.63, 40.15,
37.46, 35.25, 31.91, 29.69, 29.65, 29.54, 29.43, 29.41,
29.35, 29.28, 24.79, 22.68, 14.12. 31 P NMR (500 MHz,
CDCl3, ppm): δ -1.92, -1.98, -2.17, -2.31. HRMS (ESI+)
m/z Calculated for C50H66N5O10P1 (MH+): 928.4619,
found 928.4615.
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To a stirring solution of 38 (0.2 g, 0.21 mmol) in THF,
K2CO3 (60 mg, 4.31 mmol) and water (2 mL) is added.
To this Pd (10%) on charcoal is added and kept for stir-
ring at rt under hydrogen for 12 h. After completion,
the reaction mixture is filtered on celite-545 and the
solvent is evaporated and purified by column chroma-
tography (DCM:MeOH:H2O-17:7:1) to obtain the po-
tassium salt of 39 as white solid. 1H NMR (500 MHz,
D2O, ppm): δ 8.48 (d, 1H), 8.09 (d, 1H), 6.42 (d,1H),
4.61 (br s, 1H), 4.26 (br s, 1H), 4.16 (br m, 2H, -NH2),
2.64 (m, 3H), 1.68 (m, 2H), 1.25 (m, 2H), 1.31-1.22
(m,2H), 1.01 (m, 18H, CH2), 0.66 (t, 3H, CH3).
13C NMR
(500 MHz, D2O, ppm): 176.53, 154.04, 150.78, 147.64,
139.41, 117.66, 85.66, 83.89, 74.11, 70.77, 70.49, 64.73,
61.14, 58.56, 41.62, 40.05, 39.94, 35.24, 35.05, 33.61,
31.40, 29.34, 29.23, 28.91, 28.02, 24.66, 22.09, 13.37. 31P
NMR(500 MHz, D2O, ppm): δ -1.04, -1.12. HRMS (ESI-)
m/z Calculated for C28H48N5O8P1 (MH-): 612.3167,
found: 612.3173.3′-O-benzyloxycarbonyl thymidine 5′-(O-(benzyl
stearate)-3-yl, O-benzyl)-phosphate (41)
To a stirring solution of 15 (0.3 g, 0.77 mmol) and 13
(0.734 g, 1.16 mmol) in 5 mL dry DCM was added
0.5 M solution of 1H-tetrazole (12.5 mL, 6.22 mmol)
drop wise at 0?C, and the reaction mixture was stirred at
room temperature for 12 h. Then the reaction mixture
was cooled down to -78?C and hydrogen peroxide 35%
(W/V) was added. After stirring for 5 min at -78?C, cool-
ing bath was removed and the reaction mixture was
allowed to stir at rt for 30 min. The reaction mixture is
diluted with DCM and washed with 1 M phosphoric
acid, 5% aq. sodium bicarbonate and with brine, dried
over sodium sulfate, filtered and concentrated on vacuo,
purified by column chromatography (EtOAc) which gives
41 as an oil. 1H NMR (500 MHz, CDCl3, ppm): δ 9.27 (br
s, 1H, NH), 7.43-7.31 (m, 15H, 3 ? Ar-H), 6.37 (m, 1H),
5.16 (s, 2H, Ar-CH2), 5.12-5.03 (m, 4H, Ar-CH2), 4.86 (m,
1H), 4.18 (m, 2H), 2.74-2.64 (m, 2H), 2.36 (m, 1H),2.03
(m, 1H), 1.89 (d, 2H), 1.69 (m, 2H), 1.25 (m, 26H, -CH2),
0.89 (t, 3H, CH3).
1H NMR (300 MHz, CDCl3, ppm): δ
169.87, 163.75, 154.36, 150.49, 135.63, 135.59, 135.11,
135.02, 134.76, 134.73, 128.85, 128.76, 128.68, 128.63,
128.50, 128.46, 128.36, 128.28, 128.09, 128.01, 127.95,
111.81, 111.73, 84.52, 84.44, 82.59, 82.48, 78.07, 78.02,
70.22, 70.20, 69.87, 69.80, 69.70, 69.63, 67.13, 67.06,
67.00, 66.72, 66.68, 40.25, 40.18, 40.12, 37.28, 37.20,
35.39, 31.97, 29.75, 29.71, 29.69, 29.60, 29.51, 29.41, 29.38,
24.91, 24.85, 22.71, 14.18, 12.44. 31P NMR(300 MHz,
CDCl3): δ -1.68, -1.86, -2.06, -2.25. HRMS (ES+) m/z
Calculated for C50H67N2O12P1 (MH+): 919.4504, found
919.4498.Thymidine-5′-(O-stearic acid-3-yl)-phosphate (42)
To the stirring solutions of 41 (2 g, 2.17 mmol) in THF:
MeOH-1:1 (30 mL) was added Pd (10%) on charcoal,
and kept for stirring under hydrogen for 6 h at room
temperature. After completion of the reaction (monitored
by TLC), the reaction mixture is passed through celite pad
and the celite pad is washed with THF-MeOH mixture
(200 mL). The organic solvents were removed under vac-
uum, and the obtained white residue was purified by silica
gel chromatography using DCM:MeOH:H2O-17:7:1. The
organic solvents were removed in the rotavapor and the
aqueous solvent was removed by lyophilization to obtain
the desired product 42 as white solid (0.94 g, 71%). 1H
NMR (500 MHz, D2O, ppm): δ 7.84 (br m, 1H), 6.32 (br
m, 1H), 4.60 (br m, 2H), 4.16 (m, 3H), 2.61 (m, 2H), 2.39
(m, 2H), 1.94 (s, 3H), 1.72 (m, 2H), 1.21 (m, 26H, CH2),
0.83 (s, 3H, CH3).
13C NMR (500 MHz, D2O, ppm): δ
174.93, 165.58, 151.16, 136.86, 111.04, 85.69, 85.20, 84.89,
73.60, 71.08, 70.80, 65.06, 64.67, 40.54, 39.33, 35.21, 31.78,
29.70, 29.60, 29.28, 24.80, 22.46, 13.74, 11.86. 31P NMR
(500 MHz, CDCl3): δ -1.13, -1.15. HRMS (ES+) m/z Cal-
culated for C28H49N2O10P1 (MH-): 603.3051, found
603.3048.2′,3′-O-dibenzyloxycarbonyl, adenosine-5′-(O-(benzyl
stearate)-3-yl, O-benzyl) phosphate (44)
To a stirring solution of 16 (2 g, 3.73 mmol) and 13
(2.81 g, 4.48 mmol) in dry DCM was added 0.5 M solu-
tion of 1H-tetrazole (0.5 M in dry acetonitrile (75 ml,
37.34 mmol) dropwise at 0?C and the reaction mixture
was stirred at rt for 12 h. Then the reaction mixture was
cooled down to -78?C and hydrogen peroxide 35% was
added. After stirring for 5 min at -78?C, cooling bath
was removed and the reaction mixture was allowed to
stir at rt for 30 min. The reaction mixture is diluted with
DCM and washed with 1 M phosphoric acid, dilute so-
dium bicarbonate and with brine, dried over sodium
sulfate, filtered and concentrated in vacuo, purified by
column chromatography with eluent EtOAC to give 44
as oil. 1H NMR (500 MHz, CDCl3, ppm) : δ 8.27 (s, 1H,
H-2), 8.01-7.97 (s, 1H, H-8), 7.33-7.25 (m, 20H, 4xAr-H),
6.19 (d, 1H), 5.93-5.91 (m, 3H), 5.62 (m, 1H), 5.12-5.01
(m, 8H, CH2-Ar), 4.81 (m, 1H), 4.38 (m, 1H), 4.30-4.28
(m, 1H), 4.24-4.22 (m, 1H), 2.7-2.70 (m, 1H), 2.61-2.57 (m,
1H), 2.21 (br s, 1H), 1.67-1.60 (m, 2H), 1.25 (m, 26H),
0.89 (t, 3H, CH3).
13C NMR (500 MHz, CDCl3, ppm):
170.05, 155.70, 154.00, 153.72, 153.48, 149.90, 139.26,
135.78, 134.69, 134.54, 128.85, 128.75, 128.70, 128.64,
128.54, 128.52, 128.40, 128.06, 127.98, 120.16, 85.83,
85.79, 85.63, 80.65, 80.59, 76.66, 73.79, 70.65, 70.53,
69.67, 66.64, 65.94, 40.22, 35.31, 32.03, 29.81, 29.77,
29.68, 29.61, 29.54, 29.47, 29.40, 24.86, 22.79, 14.23. 31P
NMR (500 MHz, CDCl3, ppm): δ (q -1.96, -2.07, -2.25,
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(MH+): 1078.4937, found 1078.4946.
Adenosine-5′-(O-stearic acid-3-yl)-phosphate (45)
To the solution of 44 (0.3 g, 0.27 mmol) in THF, K2CO3
(77 mg, 0.55 mmol) and water 2 mL was added. To this
Pd (10%) on charcoal is added and held for stirring at rt
under hydrogen for 12 h. After completion of the reac-
tion, the reaction mixture is filtered on celite and the
solvent is evaporated and purified by column chroma-
tography (DCM: MeOH: H2O-17:7:1) to obtain the po-
tassium salt of 45 as white solid. 1H NMR (500 MHz,
D2O, ppm): δ 8.42 (d, 1H, H-2), 8.12 (s, 1H, H-8), 7.24
(br s, 2H, -NH2), 5.91 (d, 1H), 4.53 (m, 1H), 4.19 (m,
2H), 4.01 (br s, 1H), 3.93 (m, 2H), 2.68 (m, 1H), 2.40
(ddd, 1H), 1.91 (m, 1H), 1.60 (m, 1H), 1.45 (m, 1H), 1.23
(m, 26H, CH2), 0.86 (t, 3H, CH3).
13C NMR (500 MHz,
D2O, ppm): δ 172.50, 165.45, 155.98, 152.55, 149.58,
139.32, 139.19, 127.96, 126.94, 118.83, 86.93, 83.74, 74.01,
73.88, 71.17, 70.82, 70.64, 67.48, 64.73, 64.41, 60.48, 53.30,
47.85, 43.37, 42.56, 35.52, 31.28, 29.04, 28.69, 24.89, 22.08,
13.95. 31P NMR (500 MHz, D2O): δ -0.69. HRMS(ES-)
m/z Calculated for C28H48N5O9P1 (MH-): 628.3116, found
594.3061.
9-((O-benzyl, O-(O-benzyl stearate)-2-yl-5′ phospho),
3′-O-benzyl, 2′-O-benzyloxycarbonyl xylofuranosyl)
adenine (46)
To a stirred solution of 27 (1.2 g, 24.41 mmol) and 12
(2.3 g, 36.62 mmol) in 12 mL dry DCM was added
0.5 M solution of 1H-Tetrazole (24.41 mL, 122.07 mmol)
drop wise at 0?C, and the reaction mixture was stirred at
room temperature for 12 h. Then the reaction mixture
was cooled down to -78?C and hydrogen peroxide 35%
(W/V) was added. After stirring for 5 min at -78?C, cool-
ing bath was removed and the reaction mixture was
allowed to stir at room temperature for further 30 min.
The reaction mixture is diluted with DCM (150 mL) and
washed with 1 M phosphoric acid (100 mL), 5% aq.
sodium bicarbonate (100 mL) and with brine (80 mL),
dried over sodium sulfate, filtered and concentrated in
vacuo. The obtained residue was purified by column chro-
matography (EtOAc) giving 46 (100 mg, 4%) as an oil. 1H
NMR (300 MHz, CDCl3, ppm): δ 8.34 (s, 1H, H-2), 8.09
(m, 1H, H-8), 7.38-7.21 (m, 20H, Ar-H), 6.33 (m, 1H),
5.93 (br s, 1H), 5.41 (br s, 1H), 5.20-5.02 (m, 6H, CH2-Ar),
4.83 (m, 1H), 4.67 (m, 1H), 4.54 (m, 1H), 4.44 (m, 3H),
4.09 (br m, 1H), 1.80 (m, 2H), 1.25 (m, 26H, CH2), 0.87
(m, 3H, CH3).
13C NMR (300 MHz, CDCl3, ppm): δ
170.03, 155.58, 153.84, 153.37, 149.69, 139.24, 139.15,
136.38, 136.27, 135.73, 135.65, 135.27, 134.46, 129.04,
128.85, 128.67, 128.57, 128.47, 128.42, 128.19, 128.12,
128.06, 127.92, 119.54, 87.38, 87.33, 82.60, 82.52, 81.34,
81.23, 81.16, 80.02, 79.94, 76.04, 75.97, 72.40, 70.80, 69.87,69.82, 69.72, 69.65, 67.25, 65.37, 65.30, 65.21, 65.10, 65.03,
33.06, 32.97, 32.02, 29.80, 29.75, 29.71, 29.60, 29.45, 29.41,
29.11, 24.60, 22.78, 14.22. 31P NMR (300 MHz, CDCl3,
ppm): δ -1.58, -1.68, -1.82, -1.91. HRMS (ESI+) m/z




To a solution of 46 (100 mg, 0.09 mmol) in THF, K2CO3
(27 mg, 0.18 mmol) and water (2 mL) is added. To this
Palladium (10%) on charcoal (10 mg) is added and held
for stirring at rt under hydrogen for 12 h. After the com-
pletion of the reaction, the mixture is filtered on celite
and the solvent is removed in vacuo. The obtained residue
was purified by column chromatography with the eluent
(DCM:MeOH:H2O-17:7:1) to obtain the potassium salt of
47 as white solid. 1H NMR (300 MHz, CDCl3, ppm): δ
8.35 (m, 1H, H-2), 8.13 (s, 1H, H-8), 7.31 (d, 2H), 5.91 (br
s, 1H), 4.31 (m, 2H), 4.12 (m, 2H), 4.05 (m, 1H), 3.87 (m,
1H), 3.80-3.61 (m, 1H), 1.63 (m, 2H), 1.19 (m, 24H, CH2),
0.85 (t, CH3).
13C NMR (300 MHz, CDCl3, ppm): δ
156.06, 155.96, 152.43, 149.02, 148.78, 139.79, 118.44,
89.42, 83.62, 82.01, 80.93, 75.05, 74.87, 60.64, 59.27,
54.96, 31.34, 29.20, 28.78, 28.28, 22.12, 13.92. 31P NMR
(300 MHz, CDCl3, ppm): δ 1.67, 1.36. HRMS (ESI-) m/z
Calculated for C28H48N5O9P1 (MH-): 628.3116, found:
628.3123.
9-((O-benzyl, O-(O-benzyl stearate)-3-yl-5′ phospho),
3′-O-benzyl, 2′-O-benzyloxycarbonyl xylofuranosyl)
adenine (48)
To a stirred solution of 27 (1.2 g, 2.44 mmol) and 13
(2.3 g, 3.66 mmol) in 20 mL dry DCM was added 0.5 M
solution of 1H-Tetrazole (54 mL, 24.4 mmol) drop wise
at 0?C, and the reaction mixture was stirred at room
temperature for 12 h. Then the reaction mixture was
cooled down to -78?C and hydrogen peroxide 35% (W/V)
was added. After stirring for 5 min at -78?C, cooling bath
was removed and the reaction mixture was allowed to stir
at rt for 30 min. The reaction mixture is diluted with
DCM and washed with 1 M phosphoric acid, 5% aq.
sodium bicarbonate and with brine, dried over sodium
sulfate, filtered and concentrated in vacuo, purified by col-
umn chromatography (EtOAc) which gives 48 as an oil.
1H NMR (500 MHz, CDCl3, ppm): δ 8.33 (s, 1H, H-2),
8.10 (m, 1H, H-8), 7.38-7.19 (m, 20H, 4 ? Ar), 6.33 (d, 1H,
H-1′), 6.14 (br s, 2H, -NH2), 5.42 (br s, 1H), 5.19 (m, 2H),
5.08-5.00 (m, 4H), 4.83 (m, 1H), 4.66 (dd, 1H), 4.54 (dd,
1H), 4.38 (m, 1H), 4.35 (m, 2H), 4.10 (m, 1H), 3.55-3.46
(m, 1H), 2.77-2.72 (m, 1H, H-5′), 2.63-58 (m, 1H, H-5″),
1.66 (m, 2H, CH2), 1.25 (m, 28H, CH2), 0.89 (t, 3H, CH3).
13C NMR (500 MHz, CDCl3, ppm): δ 169.91, 155.68,
153.75, 153.22, 149.53, 139.02, 136.24, 135.82, 135.62,
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128.36, 128.27, 128.12, 128.10, 128.00, 127.92, 128.86,
119.41, 87.25, 82.44, 81.24, 79.91, 76.28, 72.27, 70.69,
69.47, 66.54, 64.92, 40.33, 35.26, 31.94, 29.71, 29.71, 29.68,
29.64, 29.56, 29.45, 29.37, 29.31, 24.76, 22.98, 22.71, 14.16.




To the solution of 48 (0.2 g, 0.21 mmol) in THF, K2CO3
(60 mg, 4.31 mmol) and water (2 mL) is added. To this
Pd (10%) on charcoal is added and held for stirring at rt
under hydrogen for 12 h. After the completion of the reac-
tion, the mixture is filtered on celite-545 and the solvent
is evaporated and the residue is purified on column chro-
matography (DCM:MeOH:H2O-17:7:1) to obtain the po-
tassium salt of 49 as white solid. H1 NMR (500 MHz,
DMSO-d6, ppm): δ 8.26 (m, 1H), 8.11 (d, 1H, H-8), 5.98
(br s, 1H), 4.63 (m, 2H), 4.46 (m, 2H), 4.25 (m, 2H), 3.60
(t, 1H), 2.44 (m, 2H), 1.78 (t, 1H), 1.55 (m, 2H), 1.06 (m,
26H, CH2), 0.74 (t, 3H, CH3).
13C NMR (600 MHz,
DMSO-d6, ppm): δ 179.31, 162.09, 154.98, 152.10, 152.03,
148.07, 147.75, 139.95, 139.86, 118.24, 118.09, 89.68,
88.46, 81.43, 81.39, 80.54, 80.11, 79.59, 75.66, 75.53, 74.57,
62.98, 62.75, 61.24, 48.57, 44.01, 35.17, 33.73, 31.45, 29.33,
29.24, 28.93, 28.12, 24.69, 24.63, 22.97, 22.17, 13.51. 31P
NMR (500 MHz, D2O, ppm): -0.94, -1.09. HRMS (ES-)




In a 100 mL two neck flask, 2′-deoxyadenosine 5′-O-
monophosphate (0.3 g, 0.9 mmol) and methyl α-
aminostearate 50 (1.42 g, 4.52 mmol) were dissolved in
a mixture of t-butanol and water (5:1). Triethylamine
(0.5 mL), and a freshly prepared solution of N, N ? -dicy-
clohexylcarbodiimide (DCC) in t-butanol (0.5 g/mL)
was added to the reaction mixture under argon atmos-
phere, and the reaction mixture was allowed to reflux
for 2 h. The progress of the reaction was monitored by
TLC. Another 5 eq of DCC was added to the reaction
mixture, and was continued refluxed under argon for
1 h. Upon completion, the reaction mixture was cooled
down to room temperature and the solvent was concen-
trated under vacuo. The residue obtained was purified
by silica gel column chromatography (DCM:MeOH:
H2O-17:7:1) to obtain 51 (0.44 g, 77%) as white solid.
1H NMR (500 MHz, DMSO, ppm): δ 8.38 (d, 1H, H-2),
8.12 (s, 1H, H-8), 7.22 (br s, 2H), 6.35 (t, 1H), 4.41 (s,
1H), 3.92 (br s, 1H), 3.78-3.74 (m, 2H), 3.67 (m, 1H),
3.55 (s, 2H), 3.52 (s, 1H), 3.02 (dd, 3H), 2.69-2.63 (m,
1H), 1.47 (m, 2H), 1.22-1.14 (m, 28H, 14xCH2), 0.85 (t,3H, CH3).
13C NMR (500 MHz, DMSO, ppm): δ 175.11,
155.95, 152.50, 149.18, 139.20, 118.86, 117.45, 82.97,
71.34, 64.14, 54.47, 51.28, 45.20, 31.26, 29.01, 28.87,
28.73, 28.67, 24.94, 22.07, 13.93, 8.46. 31P NMR (500 MHz,
DMSO): δ 4.51. HRMS (ESI+) m/z Calculated for
C29H50N6O7P1(MH-): 625.3483 found 625.3453.
2′-deoxyadenosine-5′-(N-stearic acid-2-yl)-phosphoramidate
(52)
A solution of 51 (0.4 g, 0.63 mmol) in MeOH/H2O
(4:1 v/v, 3 mL, containing 0.4 M of NaOH (0.051 g,
1.27 mmol) was stirred at room temperature under ni-
trogen for 2 h. After completion of the reaction, the
solvents were removed under reduced pressure. The re-
sulted crude reaction mixture was purified by silica gel
chromatography (DCM:MeOH:H2O-17:7:1) to obtain 52
(0.28 g, 71%) as white solid. 1H NMR (500 MHz, DMSO,
ppm): δ 8.42 (d, 1H, H-2), 8.11 (d, 1H, H-8), 7.23 (br s,
2H, -NH2), 6.37 (m, 1H), 4.44 (d, 1H), 3.97 (m, 1H),
3.82-3.71 (m, 3H), 2.69 (m, 1H), 2.27 (m, 1H), 1.65 (br s,
1H), 1.21 (m, 28H), 0.85 (t, 3H). 13C NMR (500 MHz,
DMSO, ppm): δ 176.18, 156.08, 152.59, 149.31, 139.31,
119.01, 86.45, 83.21, 71.62, 64.31, 64.09, 55.13, 54.78,
31.87, 31.39, 29.14, 25.90, 25.87, 22.20, 14.06. 31P NMR
(500 MHz, DMSO): δ 7.08, 6.96. HRMS (ES-) m/z Calcu-
lated for C28H49N6O7P1 (MH-): 611.3327, found: 611.3323.
Thymidine-5′-(N-(methyl stearate)-2-yl)-phosphoramidate
(53)
In a 100 mL two neck flask, 2′-deoxythymidine 5′-O-
monophosphate (0.5 g, 1.55 mmol) and methyl α-
aminostearate 50 (2 g, 6.20 mmol) were dissolved in
a mixture of t-butanol and water (5:1). Triethylamine
(0.5 mL), and a freshly prepared solution of N, N? -dicyclo-
hexylcarbodiimide (DCC, 1.6 g, 7.75 mmol) in t-butanol
(0.5 g/mL) was added to the reaction mixture under argon
atmosphere, and the reaction was allowed to reflux for
2 h. Another 5 eq of DCC was added to the reaction
mixture which was refluxed for 1 h. Upon completion, the
reaction mixture was cooled down to room temperature
and the reaction mixture was concentrated in vacuo.
The residue obtained was purified by silica gel column
chromatography (DCM:MeOH:H2O-17:7:1) to obtain
53 (0.69 g, 72%) as white solid. 1H NMR (500 MHz,
DMSO): δ 10.82 (br s, 1H, -NH), 7.28 (d, 1H), 5.70 (m,
1H), 5.24 (s, 1H), 3.76 (br s, 1H), 2.67 (s, 2H), 1.56 (m, 2H),
1.32 (br s, 2H), 0.71 (m, 28H, 14xCH2), 0.34 (m, 3H, CH3).
13C NMR (300 MHz, DMSO, ppm): δ 175.26, 163.79,
150.50, 136.26, 109.62, 86.03, 85.92, 83.74, 70.97, 63.82,
54.54, 54.44, 51.19, 49.19, 45.10, 34.30, 31.28, 30.21,
29.03, 28.75, 28.70, 25.01, 24.62, 23.83, 22.07, 13.87,
12.06, 8.36. 31P NMR (300 MHz, DMSO, ppm): δ 3.70.
HRMS (ES-) m/z Calculated for C29H52N3O9P1 (MH-):
616.3368, found: 616.3371.
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A solution of 53 (0.5 g, 0.8 mmol) in MeOH/H2O (4:1-
v/v), was added 0.4 M NaOH (0.065 g, 1.61 mmol), and
the mixture was stirred at room temperature under ni-
trogen for 2 h. The solvent was removed under reduced
pressure. The resulting crude material was purified by
chromatography (DCM:MeOH:H2O-17:7:1) to obtain 54
(0.34 g, 69%) as white solid. 1H NMR (500 MHz, DMSO):
δ11.24 (s, 1H), 7.84 (s, 1H), 6.22 (q, 1H), 5.36 (br s, 1H),
4.31 (d, 1H), 3.86-3.72 (m, 1H), 2.12-2.01 (m, 2H), 1.80
(m, 1H), 1.76 (), 1.23 (m, 28H), 0.86 (t, 3H, CH3).
13C
NMR (500 MHz, DMSO): 176.13, 163.89, 150.58, 136.39,
109.79, 86.12, 83.84, 71.35, 71.00, 31.38, 29.12, 26.03,
25.85, 22.18, 14.05, 12.16, 12.12. 31P NMR (500 MHz,
DMSO): δ 7.29, 7.00. HRMS (ES-) m/z Calculated for
C28H49N3O9P1 (MH-): 602.3211, found 602.3210.
Bodipy (55)
8-S-Methyl Bodipy (120 mg, 0.5 mmol, prepared accord-
ing to ref. [41]) is dissolved in DMSO/DCM (1/1; v/v,
5 ml) and mixed with taurine (60 mg, 0.5 mmol) and
NaHCO3 (42 mg, 0.5 mmol). The resulting mixture is
stirred at room temperature until TLC indicates complete
consumption of the starting material, and the formation
of a highly polar compound displaying blue fluorescence.
The reaction mixture is diluted with water (10 ml) and di-
chloromethane (10 ml) and extracted. The aqueous layer
is collected and lyophilized to yield the desired product 55
as a pale yellow solid. 1H NMR(300 MHz, DMSO, ppm):
δ 7.47 (br s, 1H, -CH), 7.36 (d, 1H, -CH), 7.24 (br s, 1H,
-CH), 7.11 (d, 1H, -CH), 6.49-6.47 (m, 1H, -CH), 6.31-6.29
(m, 1H, -CH), 3.99 (t, 2H, -CH2), 2.92 (t, 2H, -CH2).
13C
NMR (500 MHz, DMSO, ppm): δ 147.79, 132.15, 129.05,
122.45, 122.18, 114.57, 113.77, 112.42, 40.42.
Vesicles preparation and visualization
Nucleolipid aggregate/vesicle formation was performed
by dissolving the nucleolipids in water or DMSO and
dilute with water or THF/dioxane (1:1) in a glass vial.
To this solution Bodipy fluorescent dye either in water,
THF or chloroform was added, vortexed for 10 seconds
to stimulate vesicle formation and set aside for 5 min.
The pH of the nucleolipids emulsion is found to be
6.82. If the pH was lowered further, the emulsion ap-
peared opalescent. An aliquot of the mixture (100 μL)
was pipetted out from this reaction mixture and spin
coated at 3000 rpm on a microscope glass plate for
2 min, resulting in a thin layer adequate for optical
microscopy.
Vesicles formed in presence of Bodipy fluorescent dye
were monitored under fluorescent microscopy and the
images were recorded with Olympus Fluoview FV1000
by carrying out excitation wavelength readings at 532 nm
with 100 ? zoom. Two fluorescent dyes were used forthe vesicle encapsulation: aqueous soluble dye 55 (sol-
uble in both water) and organic soluble dye 56 (chloro-
form/THF soluble), which were used at a concentration
of 0.5 μM.
Stability study by NMR
Samples were prepared in D2O or DMSO and the pD of
the sample was adjusted by the addition of a small vol-
ume (a few μL) of HCl or NaOH solutions in D2O
(0.1 M). 31P NMR was used to study the stability of the
nucleolipids in acidic (pH4) and in base (pH12) environ-
ment. One-dimensional 31P spectra were used as a fast
screening experiment to monitor degradation of the
conjugates. Two-dimensional 1H-31P correlation spectra
were used to characterize the 31P containing products
formed by degradation of the nucleolipids. Correlations
were established using a Proton-detected hetero-TOCSY
experiment [24] with a DIPSI spinlock of 50 ms, allowing
correlations of 31P resonances with several 1H resonances
of adjacent spin systems.
Conclusions
We have synthesized a series of amphiphiles in which
the polar group consists of an adenine or thymine nu-
cleotide and the lipid moiety is based on stearic acid.
The nucleolipids are constructed from a phosphodiester
or phosphoramidate bond formed between α- or β-
hydroxyl group or the α-amino group present on the lipid
moiety and the 5′-phosphate group of the nucleotide.
These molecules have been analyzed for their potential to
form vesicles in water. This can be considered as a model
of a protocell with a shell containing covalently bond
nucleotides, which may be used to establish an informa-
tion system in the vesicle by polymerization. The func-
tionalized lipid may function as leaving group for the
polymerization reaction and the α (or β) carboxylic acid
may catalyze phosphodiester cleavage.
The nucleolipids with a deoxyribose sugar moiety may
form small or large vesicles, rod-like structures or vesicle
aggregates. Some of these aggregates can be considered
as intermediate forms in vesicle formation or division. It
seems that a diversity of communication systems, by diffu-
sion (in/out the vesicle) or exchange of material between
vesicles (via vesicle fusion), between such vesicles exist.
Suggesting that a protocell could stay out of equilibrium
by diverse forms of material exchange.
However, we could not observe nucleotide polymer-
ization or cyclic nucleotide formation of these nucleoli-
pids, regardless of the sugar moiety that is investigated
(deoxyribose, ribose, xylose). To unravel this observa-
tion, the chemical stability of the constructs was stud-
ied. While the nucleolipids containing β-hydroxy fatty
acids are stable as well in base as in acid circumstances,
others degraded in acidic conditions. Phosphoramidate
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cleavage where the ratio between both pathways de-
pends on the nucleobase. Diester constructs with a α-
hydroxy stearic acid degraded exclusively by hydrolysis of
the phosphorus to 5′-O-nucleoside ester. To summarize,
among all investigated systems, only α-amino compounds
have shown the desired bond breakage, the only problem
being that the nucleophile is water and not the 2? - or 3? -
hydroxyl groups. Favoring the intramolecular mechanism
in order to promote polymerization, acyclic sugar moieties
such as in GNA could be considered. Also their prebiotic
relevance makes them ideal candidates to explore proto-
cells capable of simultaneous core and shell replication
[48]. As the compounds are too stable and harsh condi-
tions would destruct the material itself, more reactive spe-
cies (such as lipid imidazolates of nucleotides) need to be
synthesized to further analyze the potential polymerization
process. This research could be based on the original work
of L. Orgel [49], in which he used phosphorimidazolate
for nucleotide polymerization. Furthermore, quantitative
investigation is in order to address the interesting (hydro)
gelating properties of these new phosphodiester nucleoli-
pids in acidic aqueous environment.Methods
All reactions were performed in an inert atmosphere
(argon). Chemicals and solvents were purchased from
Sigma-Aldrich, TCI Europe, and Alfa Aesar, and were
used without further purification. Unless otherwise men-
tioned, each reaction vessel was oven dried prior to use.
Column chromatography was performed using silica gel
(63-200 mesh) obtained from the Sigma-Aldrich Com-
pany. Analytical thin-layer chromatography (TLC) was
performed on Merck pre-coated aluminum plates (silica
gel 60, F254) and visualized under 254-nm UV light.
1H,
31P and 13C NMR spectra were obtained on a Bruker
300 MHz and Bruker 500 MHz instrument at ambient
temperature in CDCl3-d3, MeOD-d4, D2O and DMSO-
d6. Chemical shifts are reported as values in parts per
million (ppm) downfield from internal standard tetra-
methylsilane (δ = 0.0 ppm) from the residual solvent sig-
nal. Splitting patterns are designated as follows: s, singlet;
d, doublet; t, triplet; m, multiplet; dd, doublet of doublet;
br, broad peak. NMR signal assignment of sugar protons
and carbons are numbered with a prime. 31P NMR chem-
ical shifts are referenced to an external 85% H3PO4 stand-
ard (d =0.000 ppm). Mass spectra were performed on a
Hewlett Packard MALDI-TOF spectrometer. Fluorescent
microscopy images were recorded by Olympus Fluoview
FV 1000 spectrometry.Competing interests
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